Top Markets
#1 Palladium Network Palladium Network +19.88%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.80%
#3 OpenEden OpenEden +13.40%
#4 MarsCoin MarsCoin +12.48%
#5 clBTC clBTC +12.08%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.74%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.57%
#8 Mantle Staked Ether Mantle Staked Ether +8.34%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#10 Kinesis Silver Kinesis Silver +6.47%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
ObsEva S.A. ObsEva S.A.

ObsEva S.A.

OBSN
Rank in Stocks #40302
ObsEva S.A. is a biopharmaceutical company focused on developing and... ObsEva S.A. is a biopharmaceutical company focused on developing and commercializing groundbreaking therapies for women facing challenges in reproductive health and pregnancy. Its product pipeline includes Linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist currently in Phase III clinical trials. Linzagolix is being evaluated for its efficacy in treating pain associated with endometriosis and heavy menstrual bleeding linked to uterine fibroids in pre-menopausal women. The firm is also progressing with Ebopiprant, an oral and selective prostaglandin F2a (PGF2a) receptor antagonist, which is in Phase II clinical trials as a once-daily treatment for preterm labor occurring between 24 and 34 weeks of gestational age. Additionally, ObsEva is developing Nolasiban, an oral oxytocin receptor antagonist in Phase I clinical trials, aimed at enhancing clinical pregnancy and live birth rates for women undergoing in vitro fertilization. ObsEva S.A. was founded in 2012 and maintains its headquarters in Geneva, Switzerland.
Share Price
$0.00156067
Last synced: 2024-05-03
Market Cap
$182.87K
Change (1 day)
-72.69%
Change (1 year)
0.00%
Country
CH
Trade ObsEva S.A. (OBSN)

Category

Healthcare
Stock price history for ObsEva S.A. (OBSN)
Highest end of day price: $0.00 on 2024-05-01

Lowest end of day price: $16.22 on 2018-07-01
Stock price history of ObsEva S.A. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2024 -92.05%
2023 -71.26%
2022 -92.71%
2021 1.17%
2020 -41.38%
2019 -73.99%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.09%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE